Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Dec 21, 2020 9:50am
100 Views
Post# 32151832

RESAAS/QuestCap bringing more customers for Covid-19 testing

RESAAS/QuestCap bringing more customers for Covid-19 testing

Park City Board of REALTORS® Partners with RESAAS to Bring Rapid COVID-19 Tests to Members


VANCOUVER, BCDec. 21, 2020 /CNW/ - RESAAS Services Inc. (TSXV: RSS) (OTCQB: RSASF), a technology platform for the real estate industry, is pleased to announce it has partnered with the Park City Board of REALTORS® (PCBoR) to bring rapid COVID-19 tests to its members.

  • PCBoR serves more than 1,000 REALTOR® members in Park City, Utah.
  • COVID-19 Rapid Tests will be supplied by RESAAS for PCBoR members to purchase.
  • PCBoR members receive a 10% discount on Rapid Tests.
  • The Rapid Tests are FDA authorized, and present results in 8 minutes.

"Our Association is committed to members' safety first and foremost. We are proud to present our members with a testing solution offered by RESAAS to supply FDA-authorized rapid tests," said Jamie Johnson, Chief Executive Officer of the Park City Board of REALTORS®. "The real estate market in Park City has enjoyed extremely strong demand this year, fueled by many people now being able to work remotely. Rapid testing brings peace of mind to our REALTORS® and clients coming to Park City."

"We are proud to continue RESAAS' commitment to enabling Real Estate Agents to return to business responsibly," said Tom Rossiter, CEO of RESAAS. "The Park City Board of REALTORS®'s leadership team has impressed us with their focus on REALTOR® safety. Together both organizations offer a solution to enable Real Estate Agents to work with their clients using new safety protocols."

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time.


<< Previous
Bullboard Posts
Next >>